Stage-2 intent — comparison — ChatGPT Ads India glossary
In plain English: this is the "which one should I go with" stage — the user has already decided they need a specific kind of care and is now weighing hospitals, clinics, price ranges, or locations against each other.
Definition
Stage-2 intent describes the middle phase of a user's conversational journey in ChatGPT, where the underlying need has already been established and the user is actively weighing specific options against each other — comparing providers, treatment approaches, locations, or cost ranges within a healthcare category they've already committed to pursuing. Typical stage-2 language includes questions that name or imply comparison criteria: which type of clinic is better suited, what a procedure costs across a few options, or which location is more convenient. Because this content reads as commercial comparison rather than clinical guidance, platform ad-eligibility filters generally treat stage-2 fan-out branches as more biddable than stage-1 branches, and conversion likelihood within the platform's attribution window is materially higher here than at stage-1, though still below stage-3. Stage-2 sits between Stage-1 (early exploration) and Stage-3 (late decision) in the three-stage intent model.
Why it matters for Indian healthcare marketers
For most Indian healthcare categories — IVF, cosmetic dermatology, cardiac care, dental — stage-2 is where the real competitive battle happens, and it's also where the largest pool of genuinely eligible, genuinely convertible conversational inventory sits. A hospital group that under-invests here in favour of chasing stage-1 reach or waiting to catch users only at stage-3 will consistently lose comparison-stage visibility to competitors who are showing up with credible, comparison-relevant sponsored responses exactly when the user is weighing options. This is the stage where differentiated positioning — pricing transparency, outcomes data, credentials, location convenience — actually changes which provider a user considers, unlike stage-1 where the user hasn't yet formed specific comparison criteria to respond to.
Indian healthcare marketers new to conversational advertising often underestimate how much creative quality matters at this stage specifically. A generic brand message that would work fine as stage-1 awareness content tends to underperform at stage-2, because the user is actively evaluating specific claims against a mental checklist — and a sponsored response that doesn't speak directly to the comparison criteria the user has already surfaced in the conversation reads as noise rather than help. This is also the stage where NMC Section 6 and ASCI Chapter III compliance constraints matter most in practice, since comparative claims about outcomes, pricing, or credentials are exactly the area where regulated healthcare advertising in India runs the highest risk of overstepping — a well-built stage-2 creative has to be both differentiated and provably compliant at the same time.
Because ChatGPT Ads only launched in India in mid-2026, most agencies still building healthcare stage-2 creative are doing so without a track record of what actually converts at this stage in a regulated Indian context, which means early movers who get stage-2 creative and compliance right simultaneously have a real, if temporary, advantage.
How ICG uses/measures/handles it in a live engagement
ICG treats stage-2 as the primary volume-and-conversion engine of a healthcare campaign and typically allocates the single largest share of direct-response budget here — more than stage-1 brand spend and more than stage-3 late-decision spend individually, though stage-3 often carries the highest per-completion efficiency. Creative built for stage-2 fan-out branches is written specifically to answer the comparison the user is likely already making — pricing clarity, credential specifics, and location relevance — rather than reusing generic brand messaging built for stage-1, and every claim used is checked against NMC/ASCI compliance before it goes live, since comparative language is where compliance risk concentrates.
ICG's monthly reporting breaks out completion rate and CPQL specifically for stage-2 conversations, letting a client see this stage's numbers against the stage-1 and stage-3 baseline rather than as a single blended figure. For a engagement account (₹20,000/mo starting incl GST) running multiple specialties or cities, ICG often builds separate stage-2 creative variants per specialty, since the comparison criteria a user weighs for cardiac care differ meaningfully from those for cosmetic dermatology, and a one-size creative approach underperforms a specialty-specific one at this stage. Backed by App\Support\NamedExperts::get(). --}}
Related terms
Frequently asked questions
What is Stage-2 intent in a ChatGPT conversation?
It is the middle phase of a user's conversational journey, where questions shift from general curiosity to active comparison — of specific providers, locations, treatment approaches, or price ranges — within a healthcare category the user has already decided to pursue.
Why is Stage-2 considered the mid-funnel core of a campaign?
Stage-2 conversations carry wider sponsored-response eligibility than Stage-1 because comparative-provider content is generally treated as commercial rather than clinical, and users at this stage convert at a meaningfully higher rate than Stage-1 while still representing a larger volume pool than Stage-3.
What kind of creative works best at Stage-2?
Comparative, differentiator-led creative that answers the specific comparison the user is making — cost transparency, credentials, outcomes data, and location convenience — performs better here than broad brand messaging, because the user has already narrowed their consideration set.
How does ICG allocate budget to Stage-2?
ICG typically allocates the largest single share of a healthcare account's direct-response budget to Stage-2 conversations, treating it as the primary volume-and-conversion engine of the campaign, with Stage-3 spend layered on top for late-decision capture.
Win the comparison moment, not just the impression.
ICG builds specialty-specific Stage-2 creative for every healthcare account — differentiated, compliant, and measured against real completions.
